These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6995540)

  • 41. Non-H-2 genes alter the H-2 determined susceptibilities in immune complex nephritis.
    Frymoyer PA; Connor BJ; Tatum AH; Gavalchin J
    Kidney Int; 1989 Oct; 36(4):545-54. PubMed ID: 2530382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pathomorphological investigation on apoferritin induced experimental crescentic glomerulonephritis].
    Maeda J; Ueda Y; Mizoguchi K; Ono H; Iidaka K
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):375-85. PubMed ID: 3747249
    [No Abstract]   [Full Text] [Related]  

  • 43. Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice.
    Jacob A; Chaves L; Eadon MT; Chang A; Quigg RJ; Alexander JJ
    Immunology; 2013 Jul; 139(3):328-37. PubMed ID: 23347386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of prostaglandin E1 and dipyridamole on disposal of colloidal carbon via glomerular mesangial channels.
    Nagamatsu T; Suzuki Y
    Jpn J Pharmacol; 1987 Sep; 45(1):1-6. PubMed ID: 3682415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of high-dose i.v. steroid (pulse) therapy on acute serum sickness in rabbits.
    Neild GH; Ivory K; Williams DG
    Br J Exp Pathol; 1982 Dec; 63(6):606-14. PubMed ID: 7150510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of prostaglandins on immune complex interaction with glomerular cells in vitro.
    Lavelle KJ; Golichowski AM; Neff LC; Yum MN
    Immunol Invest; 1985 Feb; 14(1):57-71. PubMed ID: 4039704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antinephritic effect of prostaglandin E1 on serum sickness nephritis in rats (4). Enhanced clearance of macromolecules by the reticulo-endothelial system with prostaglandin E1.
    Nagamatsu T; Suzuki Y
    Jpn J Pharmacol; 1987 Jul; 44(3):369-72. PubMed ID: 3656790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cortical infarction in rabbits with serum sickness following Cyclosporin A therapy.
    Neild GH; Ivory K; Williams DG
    Proc Eur Dial Transplant Assoc; 1983; 20():662-8. PubMed ID: 6657686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of solanine hydrochloride on experimental sensitization of the body of guinea pigs].
    Golubeva SN; Bureva VB; Andronova LM
    Zh Ushn Nos Gorl Bolezn; 1977; (4):64-8. PubMed ID: 930359
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of serum sickness in children with the BP 400 preparation].
    Rudobielska M; Baranowska M
    Wiad Lek; 1972 Aug; 25(15):1387-9. PubMed ID: 4672501
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical and immunological studies of human serum sickness].
    Gerhards KP; Ricken D
    Med Welt; 1966 Feb; 7():330-5. PubMed ID: 5974240
    [No Abstract]   [Full Text] [Related]  

  • 52. Immune mechanisms in disease.
    Gordon VH
    J Lancet; 1966 Mar; 86(3):124-32. PubMed ID: 5904646
    [No Abstract]   [Full Text] [Related]  

  • 53. Regulation of the immune response by prostaglandins.
    Goodwin JS; Ceuppens J
    J Clin Immunol; 1983 Oct; 3(4):295-315. PubMed ID: 6140268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of prostaglandin E2 inhibition of acute changes in vascular permeability.
    McLeish KR; Wellhausen SR; Stelzer GT
    Inflammation; 1987 Sep; 11(3):279-88. PubMed ID: 2820877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostaglandin E1 therapy of murine chronic serum sickness.
    McLeish KR; Gohara AF; Gunning WT; Senitzer D
    J Lab Clin Med; 1980 Sep; 96(3):470-9. PubMed ID: 6995540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of antibody synthesis by prostaglandin E as a mechanism for preventing murine immune complex glomerulonephritis.
    McLeish KR; Gohara AF; Gunning WT
    Lab Invest; 1982 Aug; 47(2):147-52. PubMed ID: 6213813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
    J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of H-2 in apoferritin-induced murine immune complex glomerulonephritis.
    Frymoyer PA; Tatum AH; Hajdu I
    Lab Invest; 1988 Jun; 58(6):674-81. PubMed ID: 3379915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic serum sickness in the mouse. Relationship of antigen dose to glomerular pathology.
    McLeish KR; Gohara AF; Gunning WT
    Nephron; 1982; 31(1):82-8. PubMed ID: 6213878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of murine immune complex glomerulonephritis with prostaglandin E2: dose--response of immune complex deposition, antibody synthesis, and glomerular damage.
    McLeish KR; Gohara AF; Stelzer GT; Wallace JH
    Clin Immunol Immunopathol; 1983 Jan; 26(1):18-23. PubMed ID: 6575881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.